Integrative Oncology
Why Choose RGCC
RGCC was launched in 2004 by genetics pioneer Dr. Ioannis Papasotiriou with a view to developing personalized treatment options to treat cancer effectively. His belief that personalized medicine using the information in a patient’s genes is the way forward. Testing for Circulating Tumor Cells, underlying
Advanced Liquid Biopsy
Our liquid biopsies represent a transformative approach to cancer testing and research, offering distinct advantages over traditional tissue biopsies. Minimally invasive and more convenient, liquid biopsies involve a simple blood draw. If you have a history of cancer in your family, a Healthy Screening is available. Treating cancer is easier in the very beginning, if you keep testing for it yearly. Additionally, unlike traditional biopsies that offer insights from one specific location in the body, liquid biopsies capture information from distant (metastatic) sites as well. This means that liquid biopsies paint a complete picture of cancer throughout the body, offering a comprehensive perspective that can be invaluable for precise treatment planning.
Testing Both Chemotherapeutic & Natural Substances
At RGCC, we understand that treatment options go beyond traditional chemotherapy. Our tests evaluate the effectiveness of over 50 hemotherapeutic agents alongside natural substances. This holistic approach not only expands treatment options for you to choose from, it also helps identify treatments that work best for you! Additionally, unlike traditional biopsies that offer insights only from one specific location in the body, liquid biopsies capture information from distant (metastatic) sites as well. This means that liquid biopsies paint a complete picture of cancer throughout the body, offering a comprehensive perspective that can be invaluable for
precise treatment planning.
